Mood Disorders Up for Children of Consanguineous Parents

Share this content:
Mood Disorders Up for Children of Consanguineous Parents
Mood Disorders Up for Children of Consanguineous Parents

THURSDAY, April 5, 2018 (HealthDay News) -- Children of first-cousin consanguineous parents are more likely to be in receipt of antidepressant or anxiolytic medications and antipsychotic medications, according to a study published online April 4 in JAMA Psychiatry.

Aideen Maguire, Ph.D., from Queen's University Belfast in the United Kingdom, and colleagues conducted a retrospective population-wide cohort study of all individuals born in Northern Ireland between Jan. 1, 1971, and Dec. 31, 1986. The final data set included 363,960 individuals alive and residing in Northern Ireland in 2014.

The researchers found that 0.2 percent of the individuals were born to consanguineous parents. Compared with children of nonrelated parents, children of first-cousin consanguineous parents were more than three times as likely to be in receipt of antidepressant or anxiolytic medications and were more than twice as likely to be in receipt of antipsychotic medications, after full adjustment for factors known to be associated with poor mental health (odds ratios, 3.01 and 2.13, respectively).

"A child of consanguineous parents is at increased risk of common mood disorders and psychoses," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »